Search research articles
Contact Us
Filters
Showing results (171-180 of 180) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 180 results.
Journal of Gastroenterology
|
January 29, 2013
Impact of anticancer treatment on recurrent obstruction in covered metallic stents for malignant biliary obstruction
Yousuke Nakai, Hiroyuki Isayama, Tsuyoshi Mukai, et al.
Hepato-Gastroenterology
|
April 14, 2012
Factors contributing to the overall survival in patients with hepatocellular carcinoma treated by sorafenib
Yuya Tsukui, Hitoshi Mochizuki, Yuji Hoshino, et al.
Scientific Reports
|
September 4, 2021
Genetic profiles of Barrett's esophagus and esophageal adenocarcinoma in Japanese patients
Mamoru Tokunaga, Kenichiro Okimoto, Naoki Akizue, et al.
Global Health & Medicine
|
September 19, 2022
No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy
Masaaki Korenaga, Kazumoto Murata, Namiki Izumi, et al.
Cancer Science
|
January 5, 2023
Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan
Hidenori Kage, Aya Shinozaki-Ushiku, Kazunaga Ishigaki, et al.
The Lancet. Infectious Diseases
|
April 13, 2015
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
Masashi Mizokami, Osamu Yokosuka, Tetsuo Takehara, et al.
Journal of Viral Hepatitis
|
September 9, 2014
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial
Masao Omata, Shuhei Nishiguchi, Yoshiyuki Ueno, et al.
Brain Stimulation
|
July 17, 2010
Consensus paper: combining transcranial stimulation with neuroimaging
Hartwig R Siebner, Til O Bergmann, Sven Bestmann, et al.
Nature Communications
|
May 29, 2014
Klebsormidium flaccidum genome reveals primary factors for plant terrestrial adaptation
Koichi Hori, Fumito Maruyama, Takatomo Fujisawa, et al.
Hepatology International
|
February 4, 2026
Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia
Yasuto Takeuchi, Ryosuke Tateishi, Shuntaro Obi, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 180) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 180 results.
Journal of Gastroenterology
|
January 29, 2013
Impact of anticancer treatment on recurrent obstruction in covered metallic stents for malignant biliary obstruction
Yousuke Nakai, Hiroyuki Isayama, Tsuyoshi Mukai, et al.
Hepato-Gastroenterology
|
April 14, 2012
Factors contributing to the overall survival in patients with hepatocellular carcinoma treated by sorafenib
Yuya Tsukui, Hitoshi Mochizuki, Yuji Hoshino, et al.
Scientific Reports
|
September 4, 2021
Genetic profiles of Barrett's esophagus and esophageal adenocarcinoma in Japanese patients
Mamoru Tokunaga, Kenichiro Okimoto, Naoki Akizue, et al.
Global Health & Medicine
|
September 19, 2022
No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy
Masaaki Korenaga, Kazumoto Murata, Namiki Izumi, et al.
Cancer Science
|
January 5, 2023
Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan
Hidenori Kage, Aya Shinozaki-Ushiku, Kazunaga Ishigaki, et al.
The Lancet. Infectious Diseases
|
April 13, 2015
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
Masashi Mizokami, Osamu Yokosuka, Tetsuo Takehara, et al.
Journal of Viral Hepatitis
|
September 9, 2014
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial
Masao Omata, Shuhei Nishiguchi, Yoshiyuki Ueno, et al.
Brain Stimulation
|
July 17, 2010
Consensus paper: combining transcranial stimulation with neuroimaging
Hartwig R Siebner, Til O Bergmann, Sven Bestmann, et al.
Nature Communications
|
May 29, 2014
Klebsormidium flaccidum genome reveals primary factors for plant terrestrial adaptation
Koichi Hori, Fumito Maruyama, Takatomo Fujisawa, et al.
Hepatology International
|
February 4, 2026
Temporal trends and regional variations in hepatocellular carcinoma etiology: a multinational study across Asia
Yasuto Takeuchi, Ryosuke Tateishi, Shuntaro Obi, et al.
Page
of 18